Background: The rising incidence of hepatocellular cancer in the US and worldwide has
sparked a renewed interest in HCC serum markers. HCC typically develops in patients with …

Hepatocellular carcinoma (HCC), one of the leading causes of cancer deaths in the world, is
offering a challenge to human beings, with the current modes of treatment being a palliative …

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths
worldwide, and each year, approximately 750,000 new cases are diagnosed. 1 Surveillance …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some
areas of the world with increasing incidence worldwide. Most of patients with HCC are …

Hepatocellular carcinoma (HCC) is one of the most frequently occurring malignancies and
has a high mortality rate. The incidence of HCC differs greatly according to the geographic …

The incidence of hepatocellular carcinoma (HCC) has been rising worldwide over the last
20 years and is expected to increase until 2030 in some countries including the United …